1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

No evidence of abnormal metabolic or inflammatory activity in the brain, rheumatoid arthritis, 2020, Mueller, Younger. [Fatigue, MRSI]

Discussion in 'Other health news and research' started by Jaybee00, Feb 11, 2020.

  1. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    1,890
    Last edited by a moderator: Feb 12, 2020
    Yessica, hinterland, Andy and 5 others like this.
  2. Milo

    Milo Senior Member (Voting Rights)

    Messages:
    2,108
    This is linked to the following paper where Dr Jarred Younger is one of the main investigator. This is following his work on brain inflammation in ME patients published last year i believe, and he had promised to look at other diseases to see whether he could find signs of inflammation.


    No evidence of abnormal metabolic or inflammatory activity in the brains of patients with rheumatoid arthritis: results from a preliminary study using whole-brain magnetic resonance spectroscopic imaging (MRSI)

    Full text

    Abstract

    Introduction/objectives
    Many individuals with rheumatoid arthritis (RA) report persistent fatigue even after management of peripheral disease activity. This study used whole-brain magnetic resonance spectroscopic imaging (MRSI) to investigate whether abnormal inflammatory activity in the central nervous system may be associated with such symptoms. We hypothesized that RA patients would show higher brain choline (CHO), myo-inositol (MI), and lactate (LAC), and higher brain temperature than healthy controls. We further hypothesized that the metabolite levels would be positively correlated with self-reported fatigue.

    Method
    Thirteen women with RA provided fatigue severity ratings and underwent whole-brain MRSI and a joint examination. Thirteen healthy controls (HC) provided comparison imaging and fatigue data. CHO, MI, LAC, and brain temperature in 47 brain regions were contrasted between groups using independent-samples t tests. Significant differences were determined using a false discovery rate (FDR)-adjusted p value threshold of ≤ 0.0023. Secondary analyses obtained correlations between imaging and clinical outcomes in the RA group.

    Results
    No brain metabolic differences were identified between the groups. In the RA group, fatigue severity was positively correlated with CHO in several brain regions—most strongly the right frontal lobe (rs = 0.823, p < 0.001). MI was similarly correlated with fatigue, particularly in the right calcarine fissure (rs = 0.829, p < 0.001). CHO in several regions was positively correlated with joint swelling and tenderness.

    Conclusions
    We conclude that abnormal brain metabolites are not a common feature of RA, but may been seen in patients with persistent fatigue or disease activity after conventional treatment


    Key Points

    • Whole-brain magnetic resonance spectroscopy revealed no metabolic abnormalities in the brain in patients with rheumatoid arthritis.

    • Brain choline levels were correlated with fatigue severity reported by RA patients and with peripheral joint swelling and tenderness.

    • Brain myo-inositol levels were similarly correlated with fatigue severity in RA patients.
     
    Last edited: Feb 12, 2020

Share This Page